|
FAM119B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13399999787956E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.46349615654162E-11 |
| Normal-vs-Stage2 |
1.283520E-02 |
| Normal-vs-Stage3 |
2.482800E-03 |
| Normal-vs-Stage4 |
1.393610E-01 |
| Stage1-vs-Stage2 |
7.457700E-02 |
| Stage1-vs-Stage3 |
3.136500E-03 |
| Stage1-vs-Stage4 |
9.71410000000228E-05 |
| Stage2-vs-Stage3 |
7.268600E-01 |
| Stage2-vs-Stage4 |
1.936950E-01 |
| Stage3-vs-Stage4 |
2.202200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.75779999947545E-08 |
| Normal-vs-AfricanAmerican |
8.480300E-02 |
| Normal-vs-Asian |
6.888100E-02 |
| Caucasian-vs-AfricanAmerican |
8.602500E-02 |
| Caucasian-vs-Asian |
1.936360E-01 |
| AfricanAmerican-vs-Asian |
7.479700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.31019999966209E-07 |
| Normal-vs-Female |
7.92120000037144E-07 |
| Male-vs-Female |
6.097000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.063190E-01 |
| Normal-vs-Age(41-60Yrs) |
4.61950000474332E-08 |
| Normal-vs-Age(61-80Yrs) |
3.12430000004582E-06 |
| Normal-vs-Age(81-100Yrs) |
5.269800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.629200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.149800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.452600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.914410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.861600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.387800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.516760E-03 |
| Normal-vs-Grade 2 |
4.97859531378708E-11 |
| Normal-vs-Grade 3 |
6.49269999999369E-05 |
| Normal-vs-Grade 4 |
3.756200E-01 |
| Grade 1-vs-Grade 2 |
5.193900E-02 |
| Grade 1-vs-Grade 3 |
2.336000E-03 |
| Grade 1-vs-Grade 4 |
2.1838999999968E-05 |
| Grade 2-vs-Grade 3 |
3.495800E-03 |
| Grade 2-vs-Grade 4 |
5.84489999955196E-07 |
| Grade 3-vs-Grade 4 |
1.556370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.74780198594726E-13 |
| Normal-vs-ccB subtype |
2.282500E-03 |
| ccA subtype-vs-ccB subtype |
1.64579999999415E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79659999993898E-07 |
| Normal-vs-N1 |
9.564200E-01 |
| N0-vs-N1 |
4.704300E-02 |
|
|
